Page last updated: 2024-09-05

lenalidomide and Deficiency, Factor 10

lenalidomide has been researched along with Deficiency, Factor 10 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hashmi, H; Maghavani, DP; Reynolds, SB	1

Other Studies

1 other study(ies) available for lenalidomide and Deficiency, Factor 10

Article	Year
Acquired factor X deficiency in a patient with multiple myeloma: a rare case highlighting the significance of comprehensive evaluation and the need for antimyeloma therapy for bleeding diathesis. BMJ case reports, 2019, Sep-16, Volume: 12, Issue:9 Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Bortezomib; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Factor X Deficiency; Humans; Immunologic Factors; Lenalidomide; Male; Melena; Middle Aged; Multiple Myeloma; Stem Cell Transplantation	2019

Article

Year

Acquired factor X deficiency in a patient with multiple myeloma: a rare case highlighting the significance of comprehensive evaluation and the need for antimyeloma therapy for bleeding diathesis.

BMJ case reports, 2019, Sep-16, Volume: 12, Issue:9

Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Bortezomib; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Factor X Deficiency; Humans; Immunologic Factors; Lenalidomide; Male; Melena; Middle Aged; Multiple Myeloma; Stem Cell Transplantation

2019